Special Drug Use Investigation for ALLERMIST (Long Term)

• Status: Completed
• Trial end date: 2014-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This post-marketing surveillance study is to investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray for long-term use in Japanese subjects with allergic rhinitis under the conditions of actual practical use.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fluticasone

Criteria

Inclusion Criteria:

• Diagnosis of allergic rhinitis

• Use ALLERMIST for the first time

• Expected to use ALLERMIST for long-term (1 year).

Exclusion Criteria:

• Subjects with infection which fluticasone is not effective

• Subjects with deep mycosis

• Subjects with hypersensitivity to fluticasone